References
- Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11:983–91.
- Vakkalanka B, Milhem M. Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review. Clin Med Insights Oncol. 2010;4:107–10.
- Hsu JT, Chen HM, Lin CY, Yeh CN, Hwang TL, Jan YY, et al. Primary angiosarcoma of the spleen. J Surg Oncol. 2005;92:312–6.
- Hara T, Tsurumi H, Kasahara S, Ogawa K, Takada J, Imai K, et al. Long-term survival of a patient with splenic angiosarcoma after resection, high-dose chemotherapy, and autologous peripheral blood stem cell transplantation. Intern Med. 2010;49:2253–7.
- Hamid KS, Rodriguez JA, Lairmore TC. Primary splenic angiosarcoma. JSLS. 2010;14:431–5.
- Falk S, Krishnan J, Meis JM. Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol. 1993;17:959–70.
- Shukla M, Basu S, Shukla VK, Kumar M. Fever, anemia, and splenomegaly: a rare presentation of splenic angiosarcoma. Indian J Med Paediatr Oncol. 2011;32:230–2.
- Maier A, Bataille F, Krenz D, Anthuber M. [Angiosarcoma as a rare differential diagnosis in spontaneous rupture of the spleen]. Chirurg. 2004;75:70–4.
- Mahony B, Jeffrey RB, Federle MP. Spontaneous rupture of hepatic and splenic angiosarcoma demonstrated by CT. AJR Am J Roentgenol. 1982;138:965–6.
- Alvite Canosa M, Alonso Fernandez L, Seoane Vigo M, Berdeal Diaz M, Perez Grobas J, Bouzon Alejandro A, et al. [Primary angiosarcoma of the spleen]. Rev Esp Enferm Dig. 2008;100:375–6.
- Thompson WM, Levy AD, Aguilera NS, Gorospe L, Abbott RM. Angiosarcoma of the spleen: imaging characteristics in 12 patients. Radiology. 2005;235:106–15.
- Montemayor P, Caggiano V. Primary hemangiosarcoma of the spleen associated with leukocytosis and abnormal spleen scan. Int Surg. 1980;65:369–73.
- Fury MG, Antonescu CR, van Zee KJ, Brennan MF, Maki RG. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11:241–7.
- Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol. 2008;26:5269–74.